Looks like my frustrations around transparency on US has finally been heard, good to see.
Very interesting dynamic at play now, as far as we know FDA submission/approval has not been made or granted so I won't be expecting any significant revenues anytime soon as they would be limited to LDT kit only. However if it's with big pharma/lab then that's a huge milestone and step forward.
Question now is will holders use this opportunity to take profits before the capital raise or stick around knowing dilution is around the corner.
Will be very interesting to see how this plays out.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $58.92M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.0¢ | $42.78K | 116.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1408 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 111109 | 2 |
View Market Depth
| Last trade - 13.47pm 31/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |